All Stories

  1. An AI-Based Solution for Denoising Fast-Acquisition [18F]FDG PET: Clinical Feasibility and Quantitative Assessment
  2. WRONG journal! It should be "European Journal of Nuclear Medicine and Molecular Imaging"
  3. Striatal dopamine D2-like receptors availability in obesity and its modulation by bariatric surgery: a systematic review and meta-analysis
  4. Targeted radionuclide therapy directed to the tumor phenotypes: A dosimetric approach using MC simulations
  5. An Optimized Methodology for Patient-Specific Therapeutic Activity Administration in Liver Radioembolization
  6. Patlak plot based on the first 30 minutes post-injection dynamic 18F-florbetaben positron emission tomography scan separates amyloid-β positive from negative studies
  7. Brain [18F]Fluorodeoxyglucose Metabolism Assessment under Hypothyroidism and Recombinant Human Thyroid-Stimulating Hormone in Comparison with Thyroid Hormone Replacement in Patients Submitted to Total Thyroidectomy
  8. Positron Emission Tomography–Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy
  9. Las relaciones de ventilación/perfusión corregidas por píxeles mejoraron la detección de defectos de perfusión no coincidentes
  10. PSMA expression in thyroid nodule
  11. 123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases
  12. Are lesion features reproducible between 18F-FDG PET/CT images when acquired on analog or digital PET/CT scanners?
  13. Asymptomatic COVID-19 positive patient suspected on FDG-PET/CT
  14. Negative affect and stress‐related brain metabolism in patients with metastatic breast cancer
  15. Principles and Constraints of Nonrigid Registration
  16. Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients
  17. Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy
  18. Using 3D anthropometric data for the modelling of customised head immobilisation masks
  19. Segmentation of pathological liver tissue with Dilated Fully Convolutional Networks: A Preliminary Study
  20. Evaluation of the attenuation correction on myocardial perfusion imaging: a phantom study
  21. Voxel-Based Computational Tools Help Liver Dosimetry Calculations of Multiple (External and Internal) Radiation Therapies
  22. Gastric GIST Incidentally Detected on 68Ga-PSMA-PET/CT
  23. Comparison of the 90Y-labelled glass microspheres liver radioembolisation dosimetry with the estimated dosimetry obtained from pre-treatment 99mTc-MAA SPECT images reconstructed with and without attenuation correction
  24. Radiopharmacology and molecular imaging of PD-L1 expression in cancer
  25. Patient-specific gamma-index analysis to evaluate 99mTc-MAA as a predictor for 90Y glass microspheres liver radioembolisation dosimetry
  26. Activity estimation and biokinetic analysis of 99mTc-DMSA in renal infant patients using a gamma camera
  27. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images
  28. Radioembolization with 90Y-Labeled Glass Microspheres: Analytical Methods for Patient-Personalized Voxel-Based Dosimetry
  29. The Importance of SPECT Imaging Attenuation Correction During Treatment Planning for 90Y-labeled Glass Microspheres Liver Radioembolization
  30. 18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer
  31. Gamma-index and dose-volume histograms (based on voxel dosimetry) to evaluate the predictive power of 99mTc-MAA SPECT maps in comparison with post-radioembolization 90Y PET maps
  32. Nuclear Medicine in Oncology
  33. Effect of reconstruction processing methods and analysis in the quantification of brain spect studies with DaTSCAN™
  34. Optimization of activity and absorbed doses calculation to target/tumor and normal liver volumes in patients submitted to yttrium-90 radioembolization with glass microspheres
  35. Nuclear medicine training in the European Union: 2015 update
  36. The influence of number of counts in the myocardium in the determination of reproducible functional parameters in gated-SPECT studies simulated with GATE
  37. Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS)
  38. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages
  39. Analysis of gated myocardial perfusion spect images based on computational image registration
  40. Estimation of the collective ionizing dose in the Portuguese population for the years 2011 and 2012, due to nuclear medicine exams
  41. Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications
  42. Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging
  43. FDG gated cardiac PET at rest and immediately after dobutamine stress
  44. Monte Carlo simulation of the basic features of the GE Millennium MG single photon emission computed tomography gamma camera
  45. The new UEMS-EACCME criteria for accreditation of live educational events (LEEs): another step forward to improve the quality of continuing medical education (CME) in Europe
  46. Phenotypes of myocardial blood perfusion related to the genetic variations of metalloproteinases 3 (MMP3) and 9 (MMP9)
  47. Texton-based diagnosis of Alzheimer's disease
  48. Image quality of myocardial perfusion-gated studies: effect of ingestion of different fat content in the reduction of extra-myocardial abdominal signal
  49. Left ventricular function influenced byMMP3gene 5A/6A polymorphism (rs3025058): a gated-SPECT study
  50. Continuing Medical Education Committee and UEMS-EACCME
  51. UEMS/EBNM endeavour – celebrations keep going!
  52. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
  53. 3D brain image-based diagnosis of Alzheimer's disease: Bringing medical vision into feature selection
  54. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease?
  55. Syllabus for Postgraduate Specialization in Nuclear Medicine – 2011/2012 Update
  56. UEMS/EBNM endeavour
  57. Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT
  58. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy
  59. [123I] FP‐CIT spect study in vascular parkinsonism and Parkinson's disease
  60. Applications of PET–CT in clinical practice: Present and future
  61. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
  62. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner
  63. Parkinsonism due to Kernohan notch: Clinical, structural, and functional imaging correlates
  64. Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18 FDG and 18 FLT PET
  65. L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
  66. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease
  67. Clinical audit in nuclear medicine
  68. Comparison of methodologies for the in vivo assessment of 18 FLT utilisation in colorectal cancer
  69. Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP‐CIT/SPECT study
  70. Frontal lobe dysfunction in sporadic hyperekplexia
  71. In vivo imaging of cellular proliferation in colorectal cancer using positron emission tomography
  72. Dementia with Lewy bodies versus Alzheimer's disease: Role of dopamine transporter imaging
  73. Corrections
  74. Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer
  75. Positron emission and computed X-ray tomography: a coming together
  76. [123I]‐FP‐CIT‐SPECT demonstrates dopaminergic deficit in orthostatic tremor
  77. In vivo Dopamine Pre-Synaptic Receptors and Antioxidant Activities in Patients with Alzheimer’s Disease, Dementia with Lewy Bodies and in Controls
  78. [ 123 I]-FP-CIT-SPECT in the early diagnosis of PD presenting as exercise-induced dystonia
  79. CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET
  80. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study
  81. Fluorodeoxyglucose positron emission tomography in clinical oncology: the referrerʼs perspective
  82. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand
  83. Nuclear Medicine in Primary Breast Cancer Imaging
  84. Typical antipsychotic drugs — D2 receptor occupancy and depressive symptoms in schizophrenia
  85. Can ROI methodology/normalised tissue activities be used instead of absolute blood flow measurements in the brain?
  86. Glucose Utilisation and Cell Proliferation in Colorectal Cancer
  87. Dopamine neurotransmission, Parkinson’s disease and SPET
  88. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
  89. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer
  90. Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET
  91. PET e SPECT em neurologia e psiquiatria: do básico às aplicações clínicas
  92. Functional imaging of malignant paragangliomas and carcinoid tumours
  93. Clinical role of positron emission tomography in oncology
  94. Functional imaging as an aid to decision-making in metastatic paraganglioma
  95. Asymptomatic patient with an increasing concentration of CEA
  96. Positron emission tomography and colorectal cancer
  97. SPECT imaging of the dopamine transporter in juvenile-onset dystonia
  98. A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy
  99. Levels of γ‐Aminobutyric Acid‐Benzodiazepine Receptors in Abstinent, Alcohol‐Dependent Women: Preliminary Findings From an 123I‐Iomazenil Single Photon Emission Tomography Study
  100. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group
  101. Patterns of brain activity in patients with epilepsy and depression
  102. Nuclear medicine in neurology and psychiatry
  103. In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
  104. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine
  105. Crisis after angiography: time for MIBG
  106. 5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine
  107. Early detection of melanoma metastases with radioiodinated methylene blue
  108. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.
  109. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy
  110. Cognitive functioning and GABAA/benzodiazepine receptor binding in schizophrenia: A 1231-iomazenil SPET study
  111. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
  112. Relationship Between SPECT Scans and Buspirone Tests in Patients with ME/CFS
  113. Wisconsin Card Sorting Task (WCST) errors and cerebral blood flow in obsessive‐compulsive disorder (OCD)
  114. Brain blood flow in anxiety disorders
  115. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole
  116. Limbic selectivity of clozapine
  117. Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography
  118. Dementia with Lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon mission tomography
  119. Initial evaluation of123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects
  120. HMPAO SPET does not distinguish obsessive–compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome
  121. Psychiatric profiles and patterns of cerebral blood flow in focal epilepsy: interactions between depression, obsessionality, and perfusion related to the laterality of the epilepsy.
  122. Thrombosis and restenosis after peripheral angioplasty: Does acute 111indium-platelet accumulation predict angioplasty outcome?
  123. In vivo effects on striatal dopamine D 2 receptor binding by the novel atypical antipsychotic drug sertindole - a 123 I IBZM single photon emission tomography (SPET) study
  124. Caudate regional cerebral blood flow in obsessive-compulsive disorder, panic disorder and healthy controls on single photon emission computerised tomography
  125. Initial evaluation of123|-5-|-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects
  126. Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia
  127. 5-HT2A receptor blockade in vivo in schizophrenic patients treated with atypical antipsychotics: Single photon emission tomography (SPET) findings
  128. Multivariate cluster analysis of dynamic [I-123]-IBZM spet dopamine D2 receptor images in schizophrenia
  129. Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography
  130. Radioiodinated methylene blue for diagnosing early melanoma metastases
  131. HMPAO SPECT in non-epileptic seizures: preliminary results
  132. The significance of increased 111indium platelet accumulation at post-angioplasty sites
  133. Polycythaemia and agoraphobia
  134. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study
  135. Pathophysiology of Chronic Left Ventricular Dysfunction
  136. Baseline Left Ventricular (LV) performance and functional recovery after revascularisation: Predictive value of absolute 18F Fluorodeoxyglucose (FDG) uptake
  137. Targeting Disseminated Melanoma with Radiolabelled Methylene Blue: Comparative bio-distribution studies in man and animals
  138. Brainstem perfusion is impaired in chronic fatigue syndrome
  139. Regional Cerebral Blood Flow in Obsessive-Compulsive Disordered Patients at Rest
  140. Schizophrenic auditory hallucinations are associated with increased regional cerebral blood flow during verbal memory activation in a study using single photon emission computed tomography
  141. Immunoscintigraphy with a 99Tcm-labelled anti-granulcyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS
  142. Brain Perfusion Abnormalities in Gilles de la Tourette's Syndrome
  143. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders
  144. Optimised interictal HMPAO-SPECT in the evaluation of partial epilepsies
  145. Clinical brain radionuclide imaging studies
  146. Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls
  147. Differentiation between Alzheimer's disease and multi‐infarct dementia: Spect vs MR imaging
  148. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride — an123I-IBZM single photon emission tomography (SPET) study
  149. In vivo imaging of GABAA receptors using sequential whole-volume iodine-123 iomazenil single-photon emission tomography
  150. Dopamine receptor availability in Tourette's Syndrome
  151. Dopamine receptor availability in Tourette's syndrome
  152. Recognition of Mental State Terms
  153. Clinical experience with a multidetector SPET system (Toshiba GCA-9300A)
  154. Chronic fatigue syndrome Role of psychological factors overemphasised
  155. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia
  156. Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a 99mTc-HMPAO single photon emission tomography (SPET) study
  157. Striatal dopamine receptor binding in epileptic psychoses
  158. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.
  159. D2 Dopamine Receptor Binding in the Basal Ganglia of Antipsychotic-Free Schizophrenic Patients
  160. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone
  161. 99mTc-HMPAO single photon emission tomography in late life depression: a pilot study of regional cerebral blood flow at rest and during a verbal fluency task
  162. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study
  163. Elevated frontal cerebral blood flow in Gilles de la Tourette syndrome: A 99Tcm-HMPAO SPECT study
  164. Assessment of myocardial viability with 201T1 SPET and reinjection technique
  165. Demonstration of human motor cortex activation using SPECT
  166. Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems.
  167. rCBF abnormalities detected, and sequentially followed, by SPECT in neuro-Behcet's syndrome with normal CT and MRI imaging
  168. Cerebral Blood Flow Abnormalities in Adults with Infantile Autism
  169. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia
  170. Vasodilator myocardial perfusion imaging: demonstration of local electrophysiological changes of ischaemia
  171. Postviral fatigue syndrome.
  172. SPECT in epilepsy
  173. Physical assessment of the GE/CGR Neurocam and comparison with a single rotating gamma-camera
  174. Diagnosing Alzheimer's disease.
  175. Thallium Myocardial Perfusion Tomography in Clinical Cardiology
  176. Clinical Applications
  177. Clinical Case Material
  178. Image Interpretation
  179. Imaging Techniques
  180. Introduction
  181. Radiopharmaceuticals
  182. Stress Techniques
  183. The Future
  184. Endocardial monophasic action potential recordings for the detection of muocardial ischemia in man: A study using atrial pacing stress and myocardial perfusion scintigraphy
  185. Single photon emission tomography in Alzheimer's disease. A longitudinal study of changes in relative regional cerebral blood flow
  186. Single photon emission tomography in growth-hormone related Creutzfeldt-Jakob disease
  187. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime
  188. The use of cerebral activation procedures with single photon emission tomography
  189. 99TCm-HMPAO SPECT studies in traumatic intracerebral haematoma.
  190. A Historical and Philosophical Review of Localizing Brain Function
  191. Activation Protocols in Normal Subjects Using SPET: A Window into Normal Brain Function
  192. Activation Studies in Specific Disease States: Future Applications
  193. Clinical Use of SPET Imaging in Psychiatric and Neurological Disease
  194. Description and Principles of Neuroactivation
  195. Models of Brain Processing with Respect to Functional Neuroimaging
  196. Neuroactivation and Neuroimaging with SPET
  197. Principles of Emission Tomography
  198. Radiopharmaceutical Ligands and Tracers
  199. Review of Previous SPET Neuroactivation Studies in Normal Controls
  200. SPET Instrumentation: Characteristics and New Developments
  201. The use of cerebral activation procedures with single photon emission tomography
  202. In vivo characterisation of 3-iodo-6-methoxybenzamide123I in humans
  203. Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool
  204. Regional cerebral blood flow (rCBF) during migraine using 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) and single photon emission tomography (SPET)
  205. 99Tcm-HMPAO SPET and cerebral blood flow
  206. Intracellular localization of 99Tcm-d, 1-HMPAO and 201T1-DDC in rat brain
  207. DIAGNOSIS OF HERPES SIMPLEX ENCEPHALITIS BY SINGLE PHOTON EMISSION TOMOGRAPHY
  208. ROLE OF ROUTINE FUNCTIONAL BRAIN IMAGING IN TEMPORAL LOBE EPILEPSY
  209. 99mTc-HMPAO WASHOUT FROM BRAIN
  210. Technetium-99m Pentavalent DMSA Imaging Detects Metastases of Poorly Differentiated Carcinoma of the Thyroid
  211. The investigation of Alzheimer's disease with single photon emission tomography.
  212. 99mTc-HMPAO WASHOUT IN PROGNOSIS OF STROKE
  213. White cells radiolabelled with 111IN AND 99Tcm- a study of relative sensitivity and in vivo viability
  214. RADIONUCLIDE IMAGING OF SCROTUM
  215. TRANSIENT LEUCOPENIA INDUCED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
  216. IMAGING CEREBRAL DAMAGE IN HIV INFECTION
  217. Functional imaging of the brain
  218. Stress induced right ventricular dysfunction: An indication of reversible right ventricular ischaemia
  219. The in vivo distribution of 99Tcm-HM-PAO in normal man
  220. REGULAR CEREBRAL BLOOD FLOW MAPPING WITH 99mTc-LABELLED COMPOUND